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Introduction
Inhalation anesthesia is associated with a dose-dependent cardiovascular and respiratory depression 1 . Balanced anesthesia is often used to decrease inhalant anesthetic requirement, thereby limiting cardiovascular depressant effects and providing additional analgesia 2, 3 .
Butorphanol, a synthetic narcotic agonist-antagonist (μ -receptor antagonist and k-receptor agonist), is commonly used in equine medicine and is considered an efficacious and safe visceral analgesic in adult horses [4] [5] [6] . Causes minimal cardiovascular and respiratory effects in adult horse 7, 8 and contributes to the management of balanced anesthesia 9 .
The use of butorphanol in horses with abdominal pain is controversial. Even though it provides considerable visceral analgesia, it promotes gastrointestinal changes, decrease in gastrointestinal sounds, reduction in fecal output, and production of dry feces, as well as changes in behavior such as excitement, increased locomotor activity, tremors, pawing and ataxia 6 .
According to Sellon et al. 8 , a continuous rate infusion (CRI) of butorphanol at 23 µg kg -1 hour -1 in healthy horses, compared to a bolus administration of 0.13 mg kg -1 in the immediate postoperative period, was useful for pain management.
The continuous rate infusion had less impact upon gastrointestinal function than the bolus. Moreover, the use of a continuous rate infusion for postoperative analgesia in horses with colic (13 µg kg -1 hour -1 ) provided less weight loss and faster hospital discharge 10 .
The purpose of this study was to investigate the changes in cardiopulmonary parameters, serum cortisol concentrations, quality of recovery, and postoperative gastrointestinal motility in horses isoflurane-anesthetized and submitted a CRI of butorphanol.
The authors hypothesized that a CRI of butorphanol would not cause clinically relevant changes in cardiopulmonary variables and postoperative gastrointestinal motility, but would improve the quality of recovery and decrease serum cortisol concentrations.
Methods
The study and experimental design were approved by the local Institutional Animal Care and Use committee (protocol number 005866). Twelve adult, intact, male horses aged 3 ± 1 years and weighing 332 ± 55 kg were included in the study. All the horses were healthy as determined by physical examination and whole blood count. The animals were equally and randomly distributed into two groups, butorphanol group (BG) and control group (CG), and submitted to orchiectomy. 
Effects of a continuous rate infusion of butorphanol in isoflurane-anesthetized horses on cardiorespiratory parameters, recovery quality, gastrointestinal motility and serum cortisol concentrations
Measurements were started immediately before administration of butorphanol or saline (T0). Subsequent recordings were at 15 minute intervals after the start of the CRI for a total of 75 minutes (T15, T30, T45, T60, T75). The studied variables were as follows: heart rate (HR), respiratory rate (f R Isoflurane and the butorphanol infusion were discontinued after T75 and the horses were transported to the recovery stall. The quality of anesthetic recovery was evaluated using scores, according to the scale proposed by Borges et al. 11 : score 1, excellent (stands at first attempt, after the animal assumes sternal recumbency); score 2, very good (stands at second or third attempt, after the animal assumes sternal recumbency); score 3, good (stands at fourth attempt, after the animal assumes sternal recumbency; without excitation); score 4, regular (stands after more than four attempts, after the animal assumes sternal recumbency; significant ataxia); and score 5, poor (multiple attempts to stand; evident excitation; high risk of injuries).
Blood was collected for measurement of serum cortisol concentration at T0, T60, and 30 (T+30) and 1140 (T+1140) minutes after the animal stood up (approximately 2 and 19 hours after surgery, respectively). In order to minimize the effects of the circadian variation of cortisol, animals from both groups were equally distributed into two periods: morning and evening. Therefore, of the six animals belonging to each experimental group, three underwent anesthesia and surgery during the morning and the rest during the evening. Eight mL of venous blood (jugular vein) were collected in 10 mL assay tubes, without anticoagulant, which were refrigerated for 2 to 4 hours at the temperature of 5 ºC. They were then centrifuged (3000 rpm for 10 minutes) to obtain serum and stored in 1. 
Results
The cardiopulmonary parameters and blood gas values did not show any significant difference between the groups (Tables 1 and 2 
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The median scores of gastrointestinal motility at T+30
and T+60 were significantly higher in CG compared to BG (Table   4 ). There were no differences in cortisol concentrations between groups (Table 5 ).
Discussion
The continuous rate infusion of butorphanol did not promote significant changes in cardiopulmonary variables evaluated. This result is consistent with results of previous studies indicating that butorphanol does not significantly alter cardiorespiratory function in horses after administration intramuscular, intravenuous or at continuous rate infusion 7, 8, 13, 14 .
Both groups had respiratory acidosis. Although a larger number of animals in the butorphanol group (3/6) has need of intervention with IPPV to reach the limit for PE´CO 2 , the statistical analysis showed that the need for IPPV does not depend on butorphanol infusion.
The mean cortisol values found in both groups varied from 2.81 ± 1.29 to 9.88 ± 2.65 µg dL -1 , suggesting that the animals suffered some degree of pain or stress, as these values were higher than the reference interval for the species (1.3 to 2.9 µg dL -1 ). The mean values in treatment B, despite of no statistical differences, were slightly higher than in treatment C at T60, T+30 and T+1140. This difference was not anticipated because one would expect that the animals in BG, which received the opioid during the surgical period, would suffer less stress due to the supposed analgesia, as was reported by Sellon et al. 10 , who observed a reduction in cortisol concentrations in horses submitted to continuous rate infusion of butorphanol after celiotomy. However, it is this increased cortisol could have been caused by the effect of butorphanol, as observed by Pascoe et al. 15 , where the use of a synthetic kappa opioid agonist (U5088H) resulted in increased cortisol concentrations in primates, which was not observed with mu and delta opioid agonists. As in the study of Sanz et al. 14 , where the horses receiving butorphanol as an analgesic in postoperative orchiectomy had higher values of plasma cortisol that horses receiving phenylbutazone.
The quality of recovery (score 3 in both groups) and the time required for anesthetic recovery (21 ± 6 in CG and 22 ± 8 minutes in BG) were equivalent in both groups, in such a way that the continuous rate infusion of butorphanol, in the conditions of this study, did not interfere with these parameters. The same observation was made by Lascurain et al. 16 , who used three different doses of butorphanol (0.025; 0.05 and 0.075 mg kg -1 ) and did not notice a difference in the quality of recovery in horses.
In this study, a significant reduction in motility was observed between groups at T+30 and T+60, where less motility was observed in BG. Sanchez et al. 17 Similarly, individual variance cannot be excluded as a possible interference factor for the reduction in motility in BG, as one animal from the group showed a more pronounced reduction at baseline compared to the other animals. However, even though a reduction in motility was observed in this study, it is important to recognize that it was observed for a short period of time (60 minutes). Therefore, its use in horses is viable as there was only a slight variation between the maximum and minimum values in the groups. Hence, it is likely that this is of minimal clinical importance as the animals did not show signs of discomfort or pain, and fed normally.
Conclusions
The continuous rate infusion of butorphanol in horses anesthetized with isoflurane and submitted to orchiectomy did not cause cardiopulmonary changes, but promoted decrease in gastrointestinal motility during the first 60 minutes after anesthetic recovery. The opioid infusion did not improve the quality of recovery or decrease plasma cortisol concentrations.
